MIRM
NASDAQ · Biotechnology
Mirum Pharmaceuticals Inc
$107.77
+0.64 (+0.60%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+35.97%
1Y
+114.36%
YTD
+38.04%
Open$108.85
Previous Close$107.13
Day High$110.33
Day Low$106.64
52W High$114.99
52W Low$47.89
Volume—
Avg Volume871.0K
Market Cap6.53B
P/E Ratio—
EPS$-13.60
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$87.61
Above
SMA 200
$68.12
Above
RSI (14)
56.6
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
19 analysts
Price Target
-38.1% upside
Current
$107.77
$107.77
Target
$66.73
$66.73
$36.90
$66.73 avg
$76.87
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 633.30M | 334.85M | 354.29M |
| Net Income | -28,380,663 | -13,505,312 | 95.30M |
| Profit Margin | -4.5% | -4.3% | 26.9% |
| EBITDA | 2.56M | 1.29M | 155.69M |
| Free Cash Flow | — | — | 58.63M |
| Rev Growth | +89.1% | +89.1% | +17.5% |
| Debt/Equity | 0.98 | 0.98 | 0.71 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $230.01 | +6.25% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $344.72 | +2.11% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $124.87 | +0.90% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $466.79 | +3.36% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $612.50 | +0.42% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $286.41 | +2.99% | 64.3 | 37.13B |